FDBusiness.com

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

 Breaking News
  • Continued Growth by Marston’s Marston’s, a leading British pub operator and independent brewer, has reported a 4.7% rise in underlying revenue to £553.1 million for the 26 weeks ended 30 March 2019, reflecting strong growth in its brewing business, the contribution from new openings and pub acquisitions and positive like-for-like sales in its pub businesses. Underlying operating profit at [...]...
  • UK Ethical Food and Drinks Sales Hit £8.2 Billion British consumers are increasingly eating with a conscience as latest research from Mintel reveals that last year the nation spent £8.2 billion on ethical food and drink, including organic, Fairtrade, Rainforest Alliance and Marine Stewardship Council (MSC) certified products. Over the past five years, sales of ethical food and drink have shot up by 43% [...]...
  • UK Restaurant Closures Accelerating as High Street Pressures Mount The number of restaurants in Britain fell by 2.8% in the year to March 2019, the latest edition of the Market Growth Monitor from CGA and AlixPartners reveals — with high streets in the south of England, excluding London, hit especially hard by closures. The figure equates to net closures of 768 restaurants over 12 [...]...
  • European Commission Clears Acquisition of European and Thai Businesses of BRF by Tyson Foods The European Commission has approved, under the EU Merger Regulation, the $340 million acquisition of the European and Thai Businesses of BRF of Brazil by Tyson Foods of the US. BRF’s European and Thai businesses are active throughout the poultry supply chain in Thailand, and import into and further process poultry meat in the European [...]...
  • Samworth Brothers Launches New Food-To-Go Business Samworth Brothers, the family-owned British food group, has launched a new food-to-go business and delivery service – Fresh Food For Now Company. The new venture marks the evolution of the existing Ginsters van operation into a fresh new business, offering vendors a complete food-to-go solution with an extended range of brands and products to cater [...]...

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease
September 28
10:15 2015

The Nestlé Institute of Health Sciences SA (NIHS), a fundamental research institute of the global nutrition, health and wellness company Nestlé, has signed a research collaboration agreement with AC Immune SA – a leading Lausanne-based biopharmaceutical company focused on neurodegenerative diseases. The aim of the collaboration is to develop a sensitive, minimally invasive Tau diagnostic assay for early Alzheimer’s disease (AD) by applying Nestlé’s proprietary multiplexed ultrasensitive antibody technology platform.

Tangles of Tau proteins are recognised as one of two major hallmarks of neurodegeneration, the other being beta-amyloid (Abeta) plaques. Tangles and other abnormal forms of Tau protein accumulate inside the brain cells and spread between cells of people with Alzheimer’s disease over a long period of time. It is now well established that Tau correlates well with cognitive decline and disease progression. Furthermore, Tau may develop into a suitable biomarker for early diagnosis of the disease.

“This collaboration agreement opens up exciting new possibilities in the quest to better understand and combat this debilitating disease,” comments Ed Baetge, Head of NIHS. “By bringing together our ultrasensitive next-generation diagnostic platform and AC Immune’s expertise in the field, we hope to develop a minimally invasive Tau diagnostic using patients’ blood which can identify Alzheimer’s patients at a very early, and potentially pre-symptomatic, stage of the disease.”

Andrea Pfeifer, CEO of AC Immune, comments: “The development of a minimally invasive diagnostic test to identify patients at very early stages is considered as one of the most pressing needs in the treatment of Alzheimer’s disease.”

Ed Baetge adds: “Our overarching goal at NIHS is to develop nutritional approaches and technologies that help people maintain or improve their cognitive vigour especially for early diagnosis and targeted intervention to combat this global health problem.”

Nestlé’s technology is a patented diagnostic antibody-based platform capable of measuring soluble proteins with high sensitivity and specificity. The technology was developed by Prometheus Laboratories In., a Nestlé Health Science company. Since 2013, NIHS has applied it in Brain Health research, specifically in Alzheimer’s. The assay uses a triplex antibody microarray-based platform that measures the expression and activation of target proteins in tissues, blood or other fluids.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • June 18, 2019Multimodal 2019
  • June 25, 2019BevExpo 2019
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements